DN 1 - 2 - 2026
Senaste Nr DiabetologNytt i PDF
Arkiv alla nyheter

ADA Monday. Korta sammanfattning av dagens sessioner från ADA

ADA Scientific Sessions,

Gå in på nedan www,
tar 45-75 sek för nedladdning av pdf,
du kommer till en tidskrift med
1 sida per aktguellt ämne

Nyhetsinfo
www red DiabetologNytt

http://www.nxtbook.com/tristar/ada/
day3_2014/index.php

  • Banting medal winner presents lecture on ”Metabolic Messages from the Gut”
    The winner of the Banting Medal for Scientific Achievement, Dr. Daniel J. Drucker, spent three decades investigating the glucagon gene and has been involved in studies that led to DPP-4 inhibitors, GLP-1 receptor agonists and GLP-2 receptor agonists being used in diabetes and other therapeutic areas. ”The glucagon gene has already produced more approved drugs than any other gene in the human body,” Dr. Drucker said. He presented his award lecture, ”Deciphering Metabolic Messages from the Gut Drives Therapeutic Innovation,” on Sunday. ADA Diabetes Dispatch (2014) alt LinkedIn Facebook Twitter Email this Story

  • ADA presidential address highlights importance of research and advocacy
    Diabetes research funding is declining as the incidence of the disease is soaring, and more help is needed, said ADA President, Medicine & Science, Dr. Elizabeth R. Seaquist in her Sunday morning presidential address. She cited the importance of the ADA Pathway to Stop Diabetes program and other research grants, as well as the ADA’s advocacy and public awareness efforts, and emphasized the importance of ADA membership in achieving the organization’s mission to prevent and cure diabetes and improve the lives of people with diabetes. ADA Diabetes Dispatch (2014) alt LinkedIn Facebook Twitter Email this Story

  • Award winner presents research into brain control of glucose balance
    The winner of the Outstanding Scientific Achievement Award, Dr. Joel K. Elmquist, will present ”Claude Bernard Was Right — Brain Control of Glucose Homeostasis” today, a lecture that describes his research into pathways in the brain that regulate glucose homeostasis. ”The hope for the future of this work and diabetes therapy is to target these signaling pathways to increase insulin sensitivity in the peripheral tissues,” he said. ADA Diabetes Dispatch (2014) alt LinkedIn Facebook Twitter Email this Story

Facebook
LinkedIn
Email
WhatsApp